Drug Trial Radar · NCT04960202
EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19
Last checked: Nov 20, 2026Latest source record: Jul 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,091
Actual
Start
Jul 16, 2021
Primary completion
Dec 9, 2021
Study completion Apr 25, 2022
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Jul 13, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether PF-07321332/ritonavir is safe and effective for the treatment of adults who are ill with COVID-19 and do not need to be in the hospital, but are at an increased risk of developing severe illness. Throughout the study period, provision will be made to allow study visits to be conducted at a participant's home or another non-clinic location if available. The total study duration is up to 24 weeks.
Conditions
- COVID-19
Interventions
PF-07321332Drug
PF-07321332 (tablet)
RitonavirDrug
Ritonavir (capsule)
PlaceboDrug
Placebo (tablet or capsule)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Covid-19 Related Hospitalization or Death From Any Cause Through Day 28- Modified Intent-To-Treat (mITT) PopulationTime frame: From Day 1 to Day 28
Locations
201 sites in 20 countries. Site status is shown where the registry gives one.
Cahaba Research Inc
Pelham, Alabama
The Institute for Liver Health dba Arizona Clinical Trials
Mesa, Arizona
The Institute for Liver Health dba Arizona Clinical Trials
Tucson, Arizona
Hope Clinical Research
Canoga Park, California
Ascada Research
Fullerton, California
Atella Clinical Research LLC.
La Palma, California
Ark Clinical Research
Long Beach, California
American Institute of Research
Los Angeles, California
South Bay Clinical Research Institute
Redondo Beach, California
Hope Clinical Research (COVID Satellite Site)
West Hills, California
Future Innovative Treatments, LLC
Colorado Springs, Colorado
Xera Med Research
Boca Raton, Florida
MOORE Clinical Research, Inc.
Brandon, Florida
Innovative Research of West Florida, Inc.
Clearwater, Florida
Herco Medical and Research Center Inc
Coral Gables, Florida
Advance Clinical Research Group
Cutler Bay, Florida
Beautiful Minds Clinical Research Center
Cutler Bay, Florida
Qway Research
Hialeah, Florida
Eastern Research Inc
Hialeah, Florida
Inpatient Research Clinic
Hialeah, Florida
Doral Medical Research LLC.
Hialeah, Florida
Doral Medical Research,LLC
Hialeah, Florida
Unlimited Medical Research Group, LLC
Hialeah Gardens, Florida
Advanced Pulmonary Research Institute
Loxahatchee Groves, Florida
Angels Clinical Research Institute
Miami, Florida
LCC Medical Research Institute, LLC
Miami, Florida
Premium Medical Research Corp
Miami, Florida
Global Health Clinical Trials Corp
Miami, Florida
South Florida Research Center, Inc.
Miami, Florida
Suncoast Research Group, LLC
Miami, Florida
I.V.A.M. Clinical & Investigational Center, LLC
Miami, Florida
C'A Research
Miami, Florida
ProLive Medical Research, Corp.
Miami, Florida
Entrust Clinical Research
Miami, Florida
Reed Medical Research
Miami, Florida
Kendall South Medical Center
Miami, Florida
Clinical Site Partners, Inc d/b/a CSP Miami
Miami, Florida
Coral Research Clinic Corp
Miami, Florida
Savin Medical Group, LLC
Miami Lakes, Florida
Omega Research Orlando, LLC
Orlando, Florida
Showing 40 of 201 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.